Crossmark

Time for a reassessment of the treatment of hypothyroidism

Crossref DOI link: https://doi.org/10.1186/s12902-019-0365-4

Published Online: 2019-04-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Midgley, John E. M.

Toft, Anthony D.

Larisch, Rolf

Dietrich, Johannes W.

Hoermann, Rudolf
Funding

Funding for this research was provided by:

None (None)
License Information

Text and Data Mining valid from 2019-04-18
More Information

Article History

Received: 16 May 2018

Accepted: 4 April 2019

First Online: 18 April 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: JWD received funding and personal fees by Sanofi-Henning, Bristol-Myers Squibb, Hexal AG and Pfizer, and is co-owner of the intellectual property rights for the patent “System and Method for Deriving Parameters for Homeostatic Feedback Control of an Individual” (Singapore Institute for Clinical Sciences, Biomedical Sciences Institutes, Application Number 201208940–5, WIPO number WO/2014/088516). All other authors declare that they have no competing interests and there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.